BioMed Research International / 2013 / Article / Tab 3

Research Article

PSCA and Oct-4 Expression in the Benign and Malignant Lesions of Gallbladder: Implication for Carcinogenesis, Progression, and Prognosis of Gallbladder Adenocarcinoma

Table 3

Relationship between PSCA and Oct-4 expression, clinicopathological characteristics, and average survival of gallbladder adenocarcinoma patients.

Clinicopathological characteristicsSamples ( )Average survival (month) value

Sex
 Male19 10.0 (4–16)0.910
 Female4810.0 (4–18)
Age (years)
 ≤45118.0 (4–14)0.121
 >455610.0 (4–18)
Pathological types
 Adenoma812.0 (8–18)0.031
 Well2010.0 (4–18)
 Moderately2010.0 (4–18)
 Poorly128.0 (4–10)
 Mucinous A.710.0 (6–16)
Tumor size (cm)
 <22014.0 (4–18)0.003
 ≥2478.0 (4–18)
Lymph node metastasis
 No3612.0 (4–18)0.005
 Yes318.0 (4–18)
T stages
 T11012.6 (6–18)0.003
 T22611.4 (4–18)
 T3239.5 (4–18)
 T487.0 (4–10)
Operative procedure
 Radical2612.7 (4–18)<0.001
 Nonradical418.9 (4–16)
PSCA
 +359.3 (4–18)0.013
 −3211.6 (4–18)
Oct-4
 +379.5 (4–18)0.029
 −3011.5 (4–18)
PSCA + Oct-4
 PSCA (+) Oct-4 (+)248.9 (4–18)0.021
 PSCA (+) Oct-4 (−)1110.7 (4–16)
 PSCA (−) Oct-4 (+)139.7 (4–16)
 PSCA (−) Oct-4 (−)1912.5 (6–18)